Voyager Therapeutics, Inc. (VYGR) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Total Collaboration Revenue | 2.6M | FY2026-Q1 |
| Net Research and Development Expenses (Non-GAAP) | 23.2M | FY2026-Q1 |
| Net Collaboration Revenue (Non-GAAP) | 1.19M | FY2026-Q1 |
Back to VYGR overview · VYGR earnings · VYGR holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.